Exagamglogene Autotemcel

Vertex Secures FDA Approval to Expand CASGEVY Use in Young Children

BOSTON, July 1, 2026 Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the expanded...

By cGxPwire Editor
July 2, 2026

.Clinical

Vertex Reports Successful Phase 3 CASGEVY Outcomes in Pediatrics

BOSTON, June 11, 2026 Vertex Pharmaceuticals announced new Phase 3 clinical data demonstrating the potential of CASGEVY® (exagamglogene autotemcel)...

By cGxPwire Editor
June 12, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Exagamglogene Autotemcel

Vertex Secures FDA Approval to Expand CASGEVY Use in Young Children

Vertex Reports Successful Phase 3 CASGEVY Outcomes in Pediatrics